Skip to main content

Terrascend Corp(TSND-T)
TSX

Today's Change
Real-Time Last Update
Day Low2.30
Day High2.40
Open:2.35
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
GlobeNewswire
TerrAscend to Host Fourth Quarter and Full Year 2023 Earnings Conference Call
GlobeNewswire
Huxley Health Inc. Provides Corporate Update - Appoints Bruce Linton as Chairman
Baystreet
Stocks in play: TerrAscend Corp.
GlobeNewswire
Valhalla’s Innovative Extra Strength Troches Set to Hit Dispensary Shelves Throughout Pennsylvania
GlobeNewswire
TerrAscend to Present at the FONDS PROFESSIONELL KONGRESS in Germany on January 25th
GlobeNewswire
TerrAscend Reports Record Third Quarter 2023 Results and Raises Full Year 2023 Guidance
Baystreet
Stocks in play: TerrAscend Corp.
GlobeNewswire
TerrAscend to Host Third Quarter 2023 Earnings Conference Call
GlobeNewswire
TerrAscend to Participate in the Jefferies Cannabis Summit on October 25th in NYC
GlobeNewswire
TerrAscend Raises Full Year 2023 Guidance
GlobeNewswire
TerrAscend Announces September Conference Participation
GlobeNewswire
TerrAscend to Host 2023 Investor Day on October 13th at The Toronto Stock Exchange
GlobeNewswire
TerrAscend Reports Second Quarter 2023 Record Net Revenue of $72.1 Million, an Increase of 12.7% Year-Over-Year and 3.9% Sequentially, Representing its 7th Consecutive Quarter of Sequential Revenue Growth
GlobeNewswire
TerrAscend Preannounces Strong Second Quarter 2023 Revenue and Gross Margins and Provides Full Year Guidance
Baystreet
Stocks in play: TerrAscend Corp
GlobeNewswire
TerrAscend Reaches Four Dispensary Cap in Maryland with Closing of Herbiculture Acquisition
GlobeNewswire
TerrAscend Announces Symbol Change on OTC Markets to TSNDF
GlobeNewswire
TerrAscend (TSX: TSND) Commences Trading on the TSX

Profile

TerrAscend Corp is a company focused on creating and delivering quality cannabis products and services that meet the evolving needs of patients. It also provides education and support programs to physicians and patients through healthcare professionals. It has one operating segment, being cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States.